198 related articles for article (PubMed ID: 30613286)
1. Photoacoustic microscopy reveals the hemodynamic basis of sphingosine 1-phosphate-induced neuroprotection against ischemic stroke.
Cao R; Li J; Kharel Y; Zhang C; Morris E; Santos WL; Lynch KR; Zuo Z; Hu S
Theranostics; 2018; 8(22):6111-6120. PubMed ID: 30613286
[No Abstract] [Full Text] [Related]
2. Sphingosine 1-Phosphate Produced by Sphingosine Kinase 2 Intrinsically Controls Platelet Aggregation In Vitro and In Vivo.
Urtz N; Gaertner F; von Bruehl ML; Chandraratne S; Rahimi F; Zhang L; Orban M; Barocke V; Beil J; Schubert I; Lorenz M; Legate KR; Huwiler A; Pfeilschifter JM; Beerli C; Ledieu D; Persohn E; Billich A; Baumruker T; Mederos y Schnitzler M; Massberg S
Circ Res; 2015 Jul; 117(4):376-87. PubMed ID: 26129975
[TBL] [Abstract][Full Text] [Related]
3. Berberine Preconditioning Protects Neurons Against Ischemia via Sphingosine-1-Phosphate and Hypoxia-Inducible Factor-1[Formula: see text].
Zhang Q; Bian H; Guo L; Zhu H
Am J Chin Med; 2016; 44(5):927-41. PubMed ID: 27430910
[TBL] [Abstract][Full Text] [Related]
4. Sphingosine 1-Phosphate Receptors in Cerebral Ischemia.
Gaire BP; Choi JW
Neuromolecular Med; 2021 Mar; 23(1):211-223. PubMed ID: 32914259
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of sphingosine-1-phosphate receptors and sphingosine kinase 1 in the peri-ischemic area after transient middle cerebral artery occlusion in mice.
Matsumoto N; Yamashita T; Shang J; Feng T; Osakada Y; Sasaki R; Tadokoro K; Nomura E; Tsunoda K; Omote Y; Takemoto M; Hishikawa N; Ohta Y; Abe K
Brain Res; 2020 Jul; 1739():146831. PubMed ID: 32278723
[TBL] [Abstract][Full Text] [Related]
6. Sphingosine Kinase 2 Inhibition and Blood Sphingosine 1-Phosphate Levels.
Kharel Y; Morris EA; Congdon MD; Thorpe SB; Tomsig JL; Santos WL; Lynch KR
J Pharmacol Exp Ther; 2015 Oct; 355(1):23-31. PubMed ID: 26243740
[TBL] [Abstract][Full Text] [Related]
7. Sphingosine kinase 1/sphingosine-1-phosphate regulates the expression of interleukin-17A in activated microglia in cerebral ischemia/reperfusion.
Lv M; Zhang D; Dai D; Zhang W; Zhang L
Inflamm Res; 2016 Jul; 65(7):551-62. PubMed ID: 27002656
[TBL] [Abstract][Full Text] [Related]
8. Sphingosine kinase type 2 inhibition elevates circulating sphingosine 1-phosphate.
Kharel Y; Raje M; Gao M; Gellett AM; Tomsig JL; Lynch KR; Santos WL
Biochem J; 2012 Oct; 447(1):149-57. PubMed ID: 22747486
[TBL] [Abstract][Full Text] [Related]
9. Hypoxic preconditioning-induced cerebral ischemic tolerance: role of microvascular sphingosine kinase 2.
Wacker BK; Park TS; Gidday JM
Stroke; 2009 Oct; 40(10):3342-8. PubMed ID: 19644058
[TBL] [Abstract][Full Text] [Related]
10. Sphingosine kinase 2 and sphingosine-1-phosphate promotes mitochondrial function in dopaminergic neurons of mouse model of Parkinson's disease and in MPP+ -treated MN9D cells in vitro.
Sivasubramanian M; Kanagaraj N; Dheen ST; Tay SS
Neuroscience; 2015 Apr; 290():636-48. PubMed ID: 25637806
[TBL] [Abstract][Full Text] [Related]
11. Elevating Endogenous Sphingosine-1-Phosphate (S1P) Levels Improves Endothelial Function and Ameliorates Atherosclerosis in Low Density Lipoprotein Receptor-Deficient (LDL-R-/-) Mice.
Feuerborn R; Besser M; Potì F; Burkhardt R; Weißen-Plenz G; Ceglarek U; Simoni M; Proia RL; Freise H; Nofer JR
Thromb Haemost; 2018 Aug; 118(8):1470-1480. PubMed ID: 30060257
[TBL] [Abstract][Full Text] [Related]
12. Endothelial S1P
Nitzsche A; Poittevin M; Benarab A; Bonnin P; Faraco G; Uchida H; Favre J; Garcia-Bonilla L; Garcia MCL; Léger PL; Thérond P; Mathivet T; Autret G; Baudrie V; Couty L; Kono M; Chevallier A; Niazi H; Tharaux PL; Chun J; Schwab SR; Eichmann A; Tavitian B; Proia RL; Charriaut-Marlangue C; Sanchez T; Kubis N; Henrion D; Iadecola C; Hla T; Camerer E
Circ Res; 2021 Feb; 128(3):363-382. PubMed ID: 33301355
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of sphingosine 1-phosphate clearance from blood.
Kharel Y; Huang T; Salamon A; Harris TE; Santos WL; Lynch KR
Biochem J; 2020 Mar; 477(5):925-935. PubMed ID: 32065229
[TBL] [Abstract][Full Text] [Related]
14. The Intra-nuclear SphK2-S1P Axis Facilitates M1-to-M2 Shift of Microglia via Suppressing HDAC1-Mediated KLF4 Deacetylation.
Ji J; Wang J; Yang J; Wang XP; Huang JJ; Xue TF; Sun XL
Front Immunol; 2019; 10():1241. PubMed ID: 31214192
[TBL] [Abstract][Full Text] [Related]
15. FTY720 postconditions isolated perfused heart by a mechanism independent of sphingosine kinase 2 and different from S1P or ischemic postconditioning.
Vessey DA; Li L; Imhof I; Honbo N; Karliner JS
Med Sci Monit Basic Res; 2013 Apr; 19():126-32. PubMed ID: 23567658
[TBL] [Abstract][Full Text] [Related]
16. Activation of sphingosine kinase 2 is an endogenous protective mechanism in cerebral ischemia.
Pfeilschifter W; Czech-Zechmeister B; Sujak M; Mirceska A; Koch A; Rami A; Steinmetz H; Foerch C; Huwiler A; Pfeilschifter J
Biochem Biophys Res Commun; 2011 Sep; 413(2):212-7. PubMed ID: 21872577
[TBL] [Abstract][Full Text] [Related]
17. Role of the sphingosine metabolism pathway on neurons against experimental cerebral ischemia in rats.
Hasegawa Y; Suzuki H; Altay O; Rolland W; Zhang JH
Transl Stroke Res; 2013 Oct; 4(5):524-32. PubMed ID: 24187597
[TBL] [Abstract][Full Text] [Related]
18. Sphingosine kinase inhibition ameliorates chronic hypoperfusion-induced white matter lesions.
Yang Y; Torta F; Arai K; Wenk MR; Herr DR; Wong PT; Lai MK
Neurochem Int; 2016 Mar; 94():90-7. PubMed ID: 26921668
[TBL] [Abstract][Full Text] [Related]
19. Isoflurane posttreatment reduces neonatal hypoxic-ischemic brain injury in rats by the sphingosine-1-phosphate/phosphatidylinositol-3-kinase/Akt pathway.
Zhou Y; Lekic T; Fathali N; Ostrowski RP; Martin RD; Tang J; Zhang JH
Stroke; 2010 Jul; 41(7):1521-7. PubMed ID: 20508187
[TBL] [Abstract][Full Text] [Related]
20. Sphingosine 1-Phosphate Signaling Is Involved in Impaired Blood-Brain Barrier Function in Ischemia-Reperfusion Injury.
Nakagawa S; Aruga J
Mol Neurobiol; 2020 Mar; 57(3):1594-1606. PubMed ID: 31802363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
